Benzinga | Sep 3, 2021 08:00AM EDT

Ladenburg Thalmann Downgrades Forte Biosciences to Neutral

Ladenburg Thalmann analyst Michael Higgins downgrades Forte Biosciences (NASDAQ:FBRX) from Buy to Neutral.